Bone marrow conditioning regimen and Hypercalcaemia

Summary:

Hypercalcaemia is found among people with Bone marrow conditioning regimen, especially for people who are female, 60+ old.

The study analyzes which people have Hypercalcaemia with Bone marrow conditioning regimen. It is created by eHealthMe based on reports of 15 people who have Bone marrow conditioning regimen from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Bone marrow conditioning regimen?

Bone marrow conditioning regimen is found to be associated with 1 drug and 2 conditions by eHealthMe. Check the latest studies of Bone marrow conditioning regimen.

What is Hypercalcaemia?

Hypercalcaemia (elevated calcium (ca+) level in the blood) is found to be associated with 1,062 drugs and 1,017 conditions by eHealthMe. Check the latest studies of Hypercalcaemia.



On Jul, 17, 2026

15 people who have Bone Marrow Conditioning Regimen and Hypercalcaemia are studied.

Would you have Hypercalcaemia when you have Bone marrow conditioning regimen?

Gender of people who have Bone Marrow Conditioning Regimen and experienced Hypercalcaemia *:

  • female: 80 %
  • male: 20 %

Age of people who have Bone Marrow Conditioning Regimen and experienced Hypercalcaemia *:

  • 0-1: 13.33 %
  • 2-9: 13.33 %
  • 10-19: 6.67 %
  • 20-29: 6.67 %
  • 30-39: 6.67 %
  • 40-49: 6.67 %
  • 50-59: 0.0 %
  • 60+: 46.67 %

Common co-existing conditions for these people *:

  1. Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 4 people, 26.67%
  2. Insomnia (sleeplessness): 2 people, 13.33%
  3. Hypotension (abnormally low blood pressure): 2 people, 13.33%
  4. Constipation: 2 people, 13.33%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 6.67%
  6. Metastatic Lymphoma (spreadable cancer tumour of lymph node): 1 person, 6.67%
  7. Metastases To Bone (cancer spreads to bone): 1 person, 6.67%
  8. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 6.67%
  9. Delayed Engraftment: 1 person, 6.67%

Common drugs taken by these people *:

  1. Keppra: 5 people, 33.33%
  2. Cyclosporine: 3 people, 20.00%
  3. Acetazolamide: 2 people, 13.33%
  4. Mycophenolate Mofetil: 2 people, 13.33%
  5. Granisetron Hydrochloride: 2 people, 13.33%
  6. Heparin Sodium: 2 people, 13.33%
  7. Hydrocortisone Sodium Succinate: 2 people, 13.33%
  8. Famotidine: 2 people, 13.33%
  9. Zolpidem: 2 people, 13.33%
  10. Isoniazid: 2 people, 13.33%

Common symptoms for these people *:

  1. Cytomegalovirus Infection: 7 people, 46.67%
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 33.33%
  3. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 5 people, 33.33%
  4. Pneumonia: 5 people, 33.33%
  5. Hypotension (abnormally low blood pressure): 5 people, 33.33%
  6. Upper Respiratory Tract Infection: 4 people, 26.67%
  7. Troponin I Increased: 4 people, 26.67%
  8. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 4 people, 26.67%
  9. Fever: 4 people, 26.67%
  10. Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypercalcaemia?

- Check whether Hypercalcaemia is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hypercalcaemia:

All the conditions that are associated with Hypercalcaemia:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypercalcaemia and Bone marrow conditioning regimen, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: